Windgap Medical has raised $12 million from 106 investors as part of a $27 million round, according to a document filed with the SEC.
The Watertown, Mass.-based company is developing an epinephrine auto-injector designed to treat severe allergic reactions.
Get the full story at our sister site, Drug Delivery Business News.
The post Windgap Medical raises $12m for epinephrine auto-injector appeared first on MassDevice.